Effects of oleacein on high-fat diet-dependent steatosis, weight gain, and insulin resistance in Mice

Frontiers in Endocrinology

Volumn 9, Issue , 2018, Pages

  Lombardo, Giovanni Enrico ^a   Lepore, Saverio Massimo ^a   Morittu, Valeria Maria ^a   Arcidiacono, Biagio ^a   Colica, Carmela ^a   Procopio, Antonio ^a   Maggisano, Valentina ^a   Bulotta, Stefania ^a   Costa, Nicola ^a   Mignogna, Chiara ^a   Britti, Domenico ^a   Brunetti, Antonio ^a   Russo, Diego ^a   Celano, Marilena ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Cholesterol; Insulin resistance; Liver steatosis; Obesity; Oleacein

Indexed keywords

EXTRA VIRGIN OLIVE OIL; FAS ANTIBODY; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; NUTRACEUTICAL; OLEACEIN; SECOIRIDOID; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT GAIN; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EXPERIMENTAL FATTY LIVER; FOOD INTAKE; HOMEOSTASIS MODEL ASSESSMENT; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INSULINEMIA; INTRA-ABDOMINAL FAT; LIPID DIET; LIPID STORAGE; LIVER HISTOLOGY; LIVER PROTECTION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION LEVEL; WESTERN BLOTTING;

EID: 85044326689     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2018.00116     Document Type: Article

References (43)

1. Agha M, Agha R. Te rising prevalence of obesity: part A: impact on public health. Int J Surg Oncol (N Y) (2017) 2:e17. doi:10.1097/IJ9.0000000000000017
2. Kushner RF, Kahan S. Introduction: Te state of obesity in 2017. Med Clin North Am (2018) 102:1-11. doi:10.1016/j.mcna.2017.08.003
3. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 444:840-6. doi:10.1038/nature05482
4. Forbes JM, Cowan S P, Andrikopoulos S, Morley AL, Ward LC, Walker KZ, et al. Glucose homeostasis can be diferentially modulated by varying individual components of a western diet. J Nutr Biochem (2013) 24:1251-7. doi:10.1016/j.jnutbio.2012.09.009
5. Mutie PM, Giordano GN, Franks PW. Lifestyle precision medicine: the next generation in type 2 diabetes prevention. BMC Med (2017) 15:171. doi:10.1186/s12916-017-0938-x
6. Greco M, Chiefari E, Montalcini T, Accattato F, Costanzo FS, Pujia A, et al. Early efects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals. Mediators Infamm (2014) 2014:750860. doi:10.1155/2014/750860
7. Gouvinhas I, Machado N, Sobreira C, Domínguez-Perles R, Gomes S, Rosa E, et al. Critical review on the signifcance of olive phytochemicals in plant physiology and human health. Molecules (2017) 22:11. doi:10.3390/molecules22111986
8. Cicerale S, Lucas L, Keast R. Biological activities of phenolic compounds present in virgin olive oil. Int J Mol Sci (2010) 11:458-79. doi:10.3390/ijms11020458
9. Bulotta S, Celano M, Lepore SM, Montalcini T, Pujia A, Russo D. Benefcial efects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases. J Transl Med (2014) 12:219. doi:10.1186/s12967-014-0219-9
10. Barbaro B, Toietta G, Maggio R, Arciello M, Tarocchi M, Galli A, et al. Efects of the olive derived polyphenol oleuropein on human health. Int J Mol Sci (2014) 15:18508-24. doi:10.3390/ijms151018508
11. Montedoro G, Servili M, Baldioli M, Selvaggini R, Miniati E, Macchioni A. Simple and hydrolyzable compounds in virgin olive oil. 3. Spectroscopic characterizations of the secoiridoid derivatives. J Agric Food Chem (1993) 41:2228-34. doi:10.1021/jf00035a076
12. Briante R, Patumi M, Terenziani S, Bismuto E, Febbraio F, Nucci R. Olea europaea L. leaf extract and derivatives: antioxidant properties. J Agric Food Chem (2002) 50:4934-40. doi:10.1021/jf025540p
13. Flemmig J, Rusch D, Czerwinska ME, Rauwald HW, Arnhold J. Components of a standardised olive leaf dry extract (Ph. Eur.) promote hypothiocyanite production by lactoperoxidase. Arch Biochem Biophys (2014) 549:17-25. doi:10.1016/j.abb.2014.03.006
14. Costanzo P, Bonacci S, Cariati L, Nardi M, Oliverio M, Procopio A. Simple and efcient sustainable semi-synthesis of oleacein [2-(3,4-hydroxyphenyl) ethyl (3S,4E)-4-formyl-3-(2-oxoethyl)hex-4-enoate] as potential additive for edible oils. Food Chem (2018) 245:410-4. doi:10.1016/j.foodchem.2017.10.097
15. Nardi M, Bonacci S, De Luca G, Maiuolo J, Oliverio M, Sindona G, et al. Biomimetic synthesis and antioxidant evaluation of 3,4-DHPEA-EDA [2-(3,4-hydroxyphenyl) ethyl (3S,4E)-4-formyl-3-(2-oxoethyl)hex-4-enoate]. Food Chem (2014) 162:89-93. doi:10.1016/j.foodchem.2014.04.015
16. Procopio A, Alcaro S, Nardi M, Oliverio M, Ortuso F, Sacchetta P, et al. Synthesis, biological evaluation, and molecular modeling of oleuropein and its semisynthetic derivatives as cyclooxygenase inhibitors. J Agric Food Chem (2009) 57:11161-7. doi:10.1021/jf9033305
17. Lepore SM, Morittu VM, Celano M, Trimboli F, Oliverio M, Procopio A, et al. Oral administration of oleuropein and its semisynthetic peracetylated derivative prevents hepatic steatosis, hyperinsulinemia, and weight gain in mice fed with high fat cafeteria diet. Int J Endocrinol (2015) 2015:431453. doi:10.1155/2015/431453
18. Lombardo GE, Arcidiacono B, De Rose RF, Lepore SM, Costa N, Montalcini T, et al. Normocaloric diet restores weight gain and insulin sensitivity in obese mice. Front Endocrinol (2016) 7:49. doi:10.3389/fendo.2016.00049
19. Pullinger CR, Goldfne ID, Tanyolaç S, Movsesyan I, Faynboym M, Durlach V, et al. Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic- American population. Metab Syndr Relat Disord (2014) 12:25-30. doi:10.1089/met.2013.0086
20. Arcidiacono B, Iiritano S, Chiefari E, Brunetti FS, Gu G, Foti DP, et al. Cooperation between HMGA1, PDX-1, and MafA is essential for glucoseinduced insulin transcription in pancreatic beta cells. Front Endocrinol (2015) 5:237. doi:10.3389/fendo.2014.00237
21. Yang H, Lim HS, Heo YR. Sasa borealis leaves extract improves insulin resistance by modulating infammatory cytokine secretion in high fat diet-induced obese C57/BL6J mice. Nutr Res Pract (2010) 4:99-105. doi:10.4162/nrp. 2010.4.2.99
22. Sponziello M, Verrienti A, Rosignolo F, De Rose RF, Pecce V, Maggisano V, et al. PDE5 expression in human thyroid tumors and efects of PDE5 inhibitors on growth and migration of cancer cells. Endocrine (2015) 50:434-41. doi:10.1007/s12020-015-0586-x
23. Costa V, Foti D, Paonessa F, Chiefari E, Palaia L, Brunetti G, et al. Te insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-? (PPAR?) and thiazolidinedione-PPAR? agonists. Endoc Relat Cancer (2008) 15:325-35. doi:10.1677/ERC-07-0226
24. Bianconcini A, Lupo A, Capone S, Quadro L, Monti M, Zurlo D, et al. Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)/liver receptor homologue 1 (LHR-1). Int J Biochem Cell Biol (2009) 41:2189-203. doi:10.1016/j.biocel.2009.04.011
25. Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, et al. Te HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake. Mol Endocrinol (2012) 26:1578-89. doi:10.1210/me.2011-1379
26. Redinger RN. Te pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol (2007) 3:856-63.
27. Chang J W, Chen HL, Su HJ, Lee CC. Abdominal obesity and insulin resistance in people exposed to moderate-to-high levels of dioxin. PLoS One (2016) 11:e0145818. doi:10.1371/journal.pone.0145818
28. Kim Y, Choi Y, Park T. Hepatoprotective efect of oleuropein in mice: mechanisms uncovered by gene expression profling. Biotechnol J (2010) 5:950-60. doi:10.1002/biot.201000068
29. van der Stelt I, Hoek-van den Hil EF, Swarts HJM, Vervoort JJM, Hoving L, Skaltsounis L, et al. Nutraceutical oleuropein supplementation prevents high fat diet-induced adiposity in mice. J Funct Foods (2015) 14:702-15. doi:10.1016/j.jf.2015.02.040
30. Park S, Choi Y, Um SJ, Yoon SK, Park T. Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. J Hepatol (2011) 54:984-93. doi:10.1016/j. jhep.2010.08.019
31. Cao K, Xu J, Zou X, Li Y, Chen C, Zheng A, et al. Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radic Biol Med (2014) 67:396-407. doi:10.1016/j. freeradbiomed.2013.11.029
32. Beauchamp GK, Keast RSJ, Morel D, Lin J, Pika J, Han Q, et al. Ibuprofen-like activity in extravirgin olive oil. Nature (2005) 437:45-6. doi:10.1038/437045a
33. Guo S. Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol (2014) 220:T1-23. doi:10.1530/JOE-13-0584
34. Liu X, He J-F, Qu Y-T, Liu Z-J, Pu Q-Y, Sheng-Tong Guo S-T, et al. Electroacupuncture improves insulin resistance by reducing neuroprotein Y/Agouti-related protein levels and inhibiting expression of protein tyrosine phosphatase 1B in diet-induced obese rats. J Acupunct Meridian Stud (2016) 9:58-64. doi:10.1016/j.jams.2015.11.037
35. Schommers P, Turau A, Bultmann-Mellin I, Guschlbauer M, Klatt AR, Rozman J, et al. Metformin causes a futile intestinal-hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state. Mol Metab (2017) 6:737-47. doi:10.1016/j.molmet.2017.05.002
36. Brown MS, Goldstein JL. Te SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell (1997) 89:331-40. doi:10.1016/S0092-8674(00)80213-5
37. Ahmed MH, Byrne CD. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov Today (2017) 12:740-7. doi:10.1016/j.drudis.2007.07.009
38. Ji C, Chan C, Kaplowitz N. Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. J Hepatol (2006) 45:717-24. doi:10.1016/j.jhep.2006.05.009
39. Boden G, Salehi S, Cheung P, Homko C, Song W, Loveland-Jones C, et al. Comparison of in vivo efects of insulin on SREBP-1c activation and INSIG- 1/2 in rat liver and human and rat adipose tissue. Obesity (Silver Spring) (2013) 21:1208-14. doi:10.1002/oby.20134
40. Moon YA, Liang G, Xie X, Frank-Kamenetsky M, Fitzgerald K, Koteliansky V, et al. Te Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab (2012) 15:240-6. doi:10.1016/j.cmet.2011.12.017
41. Tian J, Goldstein JL, Brown MS. Insulin induction of SREBP-1c in rodent liver requires LXRa-C/EBPß complex. Proc Natl Acad Sci U S A (2016) 113:8182-7. doi:10.1073/pnas.1608987113
42. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab (2011) 13:376-88. doi:10.1016/j.cmet.2011.03.009
43. Ueyama A, Ban N, Fukazawa M, Hirayama T, Takeda M, Yata T, et al. Inhibition of MEK1 signaling pathway in the liver ameliorates insulin resistance. J Diabetes Res (2016) 2016:8264830. doi:10.1155/2016/8264830